The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives
Marjan Gharagozloo, Danny Galleguillos, Larissa Jank, Elias S. Sotirchos, Matthew D. Smith, Thomas Garton, Swati Kumar, Omar Hussein, Saahith Potluri, Michelle Taylor, Catherine Siu, Jackson W. Mace, Ted M. Dawson, Valina L. Dawson, Seulki Lee, Peter A. Calabresi
Topics & Concepts
RemyelinationNeuroprotectionAgonistMultiple sclerosisOLIG2Internal medicineMedicineEndocrinologyReceptorPharmacologyMyelinNeuroscienceOligodendrocyteBiologyCentral nervous systemImmunologyNeurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration MechanismsNeuropeptides and Animal Physiology